Safety and Efficacy of Exenatide as Monotherapy and Adjunctive Therapy to Oral Antidiabetic Agents in Adolescents With Type 2 Diabetes
Clinical trial NCT00658021 · COMPLETED
Trial details
- NCT number
- NCT00658021
- Sponsor
- AstraZeneca
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2008-05-30
- Primary completion
- 2019-04-18
- Enrollment
- 122
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.